Mankind Pharma has allotted 46,582 equity shares under its Employee Stock Option Plan 2022. The shares, with a face value of ₹1 each, were allotted to eligible employees who exercised their options. Following the allotment, the company’s paid-up share capital increased to ₹41,28,05,072. These shares rank equally with the existing equity shares.
Equity Shares Allotment
Mankind Pharma Limited announced the allotment of 46,582 equity shares on November 26, 2025, under its Employee Stock Option Plan 2022 (ESOP Plan). The decision was made via a circular resolution by the Nomination and Remuneration Committee of the Board of Directors.
Details of the Allotment
The allotted shares have a face value of ₹1 each. These shares rank pari-passu with the company’s existing equity shares. As a result of this allotment, the paid-up share capital of the company has increased from ₹41,27,58,490 to ₹41,28,05,072.
Key Information Regarding Allotment
Below is a summary of the key details regarding the equity share allotment:
Particulars
Details
Company Name
Mankind Pharma Limited
Stock Exchanges Listed
National Stock Exchange (NSE) and BSE Limited
Scheme
Mankind Employee Stock Option Plan 2022
Kind of Security
Equity Shares
Face Value
₹1 per share
Allotment Date
November 26, 2025
Number of Shares Allotted
46,582
Distinctive Number
41,27,58,491 – 41,28,05,072 (Both Inclusive)
ISIN
INE634S01028
Exercise Price
₹860.00 per equity share
Premium
₹859.00 per equity share
Total Issued Shares After Issue
41,28,05,072
Total Share Capital After Issue
₹41,28,05,072
The shares are identical in all respects to existing shares and will rank equally with the equity shares of the company.
Source: BSE